Page last updated: 2024-10-22

alendronate and Thromboembolism

alendronate has been researched along with Thromboembolism in 1 studies

alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.

Thromboembolism: Obstruction of a blood vessel (embolism) by a blood clot (THROMBUS) in the blood stream.

Research Excerpts

ExcerptRelevanceReference
"For 55 and 60 year old women with osteopenia, treatment with raloxifene compares favorably to interventions accepted as cost-effective."1.34Cost-effectiveness of preventative therapies for postmenopausal women with osteopenia. ( Johnston, JA; Klein, R; Meadows, ES; Ohsfeldt, RL; Rousculp, MD; Smolen, L, 2007)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Meadows, ES1
Klein, R1
Rousculp, MD1
Smolen, L1
Ohsfeldt, RL1
Johnston, JA1

Other Studies

1 other study available for alendronate and Thromboembolism

ArticleYear
Cost-effectiveness of preventative therapies for postmenopausal women with osteopenia.
    BMC women's health, 2007, Apr-17, Volume: 7

    Topics: Aged; Alendronate; Bone Density Conservation Agents; Bone Diseases, Metabolic; Breast Neoplasms; Cos

2007